During Friday’s trading session, shares of one of India’s leading Contract Research and Testing Organisation moved up by nearly 17 percent on BSE, after announcing financial results for Q1 FY26 with a net profit growth of 36 percent YoY.
The shares of Vimta Labs Limited closed in the green at Rs. 525.9 on BSE, up by 13 percent, as against its previous closing price of Rs. 465.5, with a market cap of Rs. 2,340.5 crores. The stock has delivered positive returns of around 97 percent in the last one year, and has gained by more than 9 percent in one month.
What’s the News:
According to the latest regulatory filings on the stock exchanges, Vimta Labs Limited announced the financial results for Q1 FY26 on Friday during market hours. For Q1 FY26, Vimta Labs reported a revenue from operations of Rs. 97.6 crores, marking around a 3 percent QoQ marginal growth compared to Rs. 94.4 crores in Q4 FY25, and a year-on-year increase of about 30 percent from Rs. 74.8 crores recorded in Q1 FY25.
The company’s net profit for the quarter stood at Rs. 19 crores, reflecting a rise of around 4 percent QoQ compared to Rs. 18.3 crores in Q4 FY25, and a year-on-year increase of about 36 percent from Rs. 14 crores recorded in Q1 FY25.
Additionally, in the same quarter, the company’s Board has approved and allotted a bonus issue in a 1:1 ratio. Vimta Labs Limited is a leading contract research and testing organisation, engaged in the business of providing food, agri, bio/pharmaceutical, medical device, speciality chemical, and electronics companies with an integrated scientific, technical, and regulatory expertise. The company also provides environmental assessments and testing services.
Written by Shivani Singh
Disclaimer
The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Trade Brains Technologies Private Limited or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
